Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Cysteine and Glycine-Rich Protein 2 (CSRP2) (Middle Region) Peptide

CSRP2 Reactivity: Mouse Host: Synthetic BP, WB
Catalog No. ABIN975381

Quick Overview for Cysteine and Glycine-Rich Protein 2 (CSRP2) (Middle Region) Peptide (ABIN975381)

Target

CSRP2 (Cysteine and Glycine-Rich Protein 2 (CSRP2))

Origin

Mouse

Source

  • 6
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Sequence

    IKPESAQPHR PTTNPNTSKF AQKYGGAEKC SRCGDSVYAA EKIIGAGKPW

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-Csrp2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    CSRP2 (Cysteine and Glycine-Rich Protein 2 (CSRP2))

    Background

    Csrp2 is drastically down-regulated in response to PDGF-BB or cell injury, that promote smooth muscle cell proliferation and dedifferentiation. It seems to play a role in the development of the embryonic vascular system.

    Alias Symbols: AW551867, Crp2, SmLim

    Protein Size: 193

    Molecular Weight

    21 kDa

    Gene ID

    13008

    NCBI Accession

    NM_007792, NP_031818

    UniProt

    P97314
You are here:
Chat with us!